Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 280

1.

High-dose radiotherapy for the treatment of inoperable non-small cell lung cancer.

Sura S, Yorke E, Jackson A, Rosenzweig KE.

Cancer J. 2007 Jul-Aug;13(4):238-42.

PMID:
17762758
2.

Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma.

Rosenzweig KE, Fox JL, Yorke E, Amols H, Jackson A, Rusch V, Kris MG, Ling CC, Leibel SA.

Cancer. 2005 May 15;103(10):2118-27.

3.

Radical radiotherapy in stage I non-small cell lung cancer (NSCLC)--Singapore National Cancer Centre experience.

Low JSh, Koh WY, Yap SP, Fong KW.

Ann Acad Med Singapore. 2007 Sep;36(9):778-83.

4.

[Treatment outcome of locally advanced stage IIIA/B lung cancer].

Cicenas S, Zaliene A, Atkocius V.

Medicina (Kaunas). 2009;45(6):452-9. Lithuanian.

5.

Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.

Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, Ryu JK, Bosch W, Emami B.

Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):318-28.

PMID:
15667949
6.

A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.

Cho KH, Ahn SJ, Pyo HR, Kim KS, Kim YC, Moon SH, Han JY, Kim HT, Koom WS, Lee JS.

Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1397-404. doi: 10.1016/j.ijrobp.2008.10.020. Epub 2008 Dec 29.

PMID:
19117690
7.

High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study.

Kong FM, Ten Haken RK, Schipper MJ, Sullivan MA, Chen M, Lopez C, Kalemkerian GP, Hayman JA.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):324-33.

PMID:
16168827
8.

Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy.

Fang LC, Komaki R, Allen P, Guerrero T, Mohan R, Cox JD.

Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):108-16.

PMID:
16904517
9.

Radiation therapy of stage I and II non-small cell lung cancer (NSCLC).

Zierhut D, Bettscheider C, Schubert K, van Kampen M, Wannenmacher M.

Lung Cancer. 2001 Dec;34 Suppl 3:S39-43.

PMID:
11740992
10.

Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer.

Rengan R, Rosenzweig KE, Venkatraman E, Koutcher LA, Fox JL, Nayak R, Amols H, Yorke E, Jackson A, Ling CC, Leibel SA.

Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):741-7.

PMID:
15465190
11.

Elective nodal failures are uncommon in medically inoperable patients with Stage I non-small-cell lung carcinoma treated with limited radiotherapy fields.

Bradley JD, Wahab S, Lockett MA, Perez CA, Purdy JA.

Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):342-7.

PMID:
12738307
12.

Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.

Moreno-Jiménez M, Aristu J, López-Picazo JM, Ramos LI, Gúrpide A, Gómez-Iturriaga A, Valero J, Martínez-Monge R.

Radiother Oncol. 2008 Sep;88(3):342-50. doi: 10.1016/j.radonc.2008.05.019. Epub 2008 Jun 14.

PMID:
18558448
13.

High-dose conformal radiotherapy for patients with stage III non-small-cell lung carcinoma.

Nakayama H, Satoh H, Kurishima K, Ishikawa H, Tokuuye K.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):645-50. doi: 10.1016/j.ijrobp.2009.08.037.

PMID:
20869582
14.

Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation?

Chen M, Hayman JA, Ten Haken RK, Tatro D, Fernando S, Kong FM.

Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):120-6. Epub 2005 Sep 29.

PMID:
16198503
15.

Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.

Caglar HB, Baldini EH, Othus M, Rabin MS, Bueno R, Sugarbaker DJ, Mentzer SJ, Jänne PA, Johnson BE, Allen AM.

Cancer. 2009 Sep 15;115(18):4156-66. doi: 10.1002/cncr.24492.

16.

Combined modality treatment of non-small-cell lung cancer.

Westeel V, Depierre A.

Am J Respir Med. 2003;2(6):477-90. Review.

PMID:
14719987
17.

Concurrent end-phase boost high-dose radiation therapy for non-small-cell lung cancer with or without cisplatin chemotherapy.

Graham PH, Clark C, Abell F, Browne L, Capp A, Clingan P, De Sousa P, Fox C, Links M.

Australas Radiol. 2006 Aug;50(4):342-8.

PMID:
16884421
18.

Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone.

Kupelian PA, Komaki R, Allen P.

Int J Radiat Oncol Biol Phys. 1996 Oct 1;36(3):607-13.

PMID:
8948345
19.

Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.

Srisam-Ang K, Podhipak A, Narksawat K, Supaattagorn P, Tipayamongkholgul M.

Southeast Asian J Trop Med Public Health. 2005 Jul;36(4):994-1006.

PMID:
16295558
20.

Has 3-D conformal radiotherapy (3D CRT) improved the local tumour control for stage I non-small cell lung cancer?

Lagerwaard FJ, Senan S, van Meerbeeck JP, Graveland WJ; Rotterdam Oncological Thoracic Study Group.

Radiother Oncol. 2002 May;63(2):151-7.

PMID:
12063004
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk